The lack of complete restoration of a normal vasodilatory response might involve (amongst others) additional mediators of pulmonary tobacco associated- endothelial dysfunction, such as increased activation of the endothelin (ET)-1/ET-A pathway (as we have previously reported [5]). The gene discussed is EDN1; the disease is endothelial dysfunction.